Health: GSK faces threat of Advair generic in US, Suntory: d...

To view this email as a webpage, click here     Wednesday September 11 2013     Health   GSK faces threat of Advair generic in US   GlaxoSmithKline's shares fall as much as 3.6% after the Food and Drug Administration proposes conditions for producing cheaper versions of drug       Suntory: driven to drinks     GSK sells Lucozade and Ribena for £1.35bn               Manage email    Forward this email   Feedback    Manage portfolio Subscribe to the FT Follow the FT   Unsubscribe | My Account | RSS | Privacy Policy | About Us | Help   © THE FINANCIAL TIMES LTD 2013 You have received this email because you have signed up from the NBE preference page. This email was sent by a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723.